# CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation

> **NCT07662369** · PHASE1,PHASE2 · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hematologic Malignancy
- Haplo-identical HCT

## Interventions

- **BIOLOGICAL:** CD45RA depleted donor lymphocyte infusion (DLI)

## Key facts

- **NCT ID:** NCT07662369
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07662369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07662369, "CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07662369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*